Review
Drug-eluting stents: limitations of early generation and progress with newer generation devices
Affiliations
- PMID: 20228717
Item in Clipboard
Review
Drug-eluting stents: limitations of early generation and progress with newer generation devices
Minerva Med.
2010 Feb.
Abstract
The success of first generation drug-eluting stents, namely by reducing restenosis and the need of repeat revascularization procedures is hampered by some limitations affecting device safety. Intense research efforts helped to identify these shortcomings and direct research to develop newer generation drug-eluting stents with the potential to circumvent these drawbacks. This review will discuss limitations of early generation drug-eluting stents, focus on solutions provided by newer generation devices, and shed light on unresolved issues and potential future solutions.
Similar articles
-
A critical appraisal of the safety and efficacy of drug-eluting stents.Clin Pharmacol Ther. 2009 May;85(5):474-80. doi: 10.1038/clpt.2009.8. Epub 2009 Mar 11. Clin Pharmacol Ther. 2009. PMID: 19279567 Review.
-
Coronary stents: looking forward.J Am Coll Cardiol. 2010 Aug 31;56(10 Suppl):S43-78. doi: 10.1016/j.jacc.2010.06.008. J Am Coll Cardiol. 2010. PMID: 20797503 Review.
-
Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550. Coron Artery Dis. 2010. PMID: 19952925 Review.
-
[Expectation for new-generation drug eluting stents].Nihon Rinsho. 2011 Feb;69(2):237-9. Nihon Rinsho. 2011. PMID: 21387669 Review. Japanese.
-
Drug-eluting stent safety.Am J Cardiol. 2007 Oct 22;100(8B):10M-17M. doi: 10.1016/j.amjcard.2007.08.017. Am J Cardiol. 2007. PMID: 17950827 Review.